Bulgaria: Denosumab, Supreme Administrative Court of Bulgaria, Administrative case 5362/2015, 23 June 2016

search-result-placeholder.jpg

The Bulgarian Supreme Administrative Court upheld a first instance judgment annulling the decision of the Bulgarian Patent Office to refuse the grant of a supplementary protection certificate for a medical product where the active ingredient was functionally defined in the patent claims rather than through its structural formula.

A full summary of this case has been published on Kluwer IP Law

Comments (0)
Your email address will not be published.
Leave a Comment
Your email address will not be published.
Clear all
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community! Contact Editorial Guidelines
Image
AI Assistant on Kluwer IP Law's Manual IP
Image
Whitepaper

Book Ad List

Books
book1
Vissers Annotated European Patent Convention 2024 Edition
Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge
€105.00
AIPPI
Experimental Use and Bolar Exemptions
David Gilat, Charles A. Boulakia, Daphné Derouane & Ralph Nack
€190.00
book2
Annotated PCT
Malte Köllner
€160.00